$17.98 -0.49 (-2.65%)
2/10/2012 4:00 PM

Alkermes, Inc. (NASDAQ:ALKS)

CAPS Rating: 4 out of 5

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

Featured Broker Partners


Advertisement